HepG2 is an immortalized cell line consisting of human liver carcinoma cells, derived from the liver tissue of a 15-year-old Caucasian male who had a well-differentiated hepatocellular carcinoma. The HepG2 cell line is commonly used in drug metabolism and hepatoxicity studies. HepG2 cells exhibit an epithelial-like morphology. They are also non-tumorigenic and have high proliferation rates.
HepG2 cells are inoculated in immunocompromised mice to create the HepG2 Cell Line Derived Xenograft (CDX) mouse model. Please refer to the research article attached below.
Article Inhibition of Tumor Growth of Human Hepatocellular Carcinoma...